Filed: 2/14/2025ACC: 0001172661-25-001157
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $212.20M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$212.20M
Total AUM (reported)
37.98M
Total Shares
Allocation by class
COM$133.02M62.7%
COM NEW$42.84M20.2%
SPONSORED ADS$12.07M5.7%
SPON ADS$11.10M5.2%
CLASS A ORD SHS$7.93M3.7%
CL A ORD SHS$5.25M2.5%
Portfolio Concentration
Top 3$49.73M23.4%
4–10$80.94M38.1%
11–25$79.53M37.5%
Rest$2.00M0.9%
Top 3 weight
23.4%
Top 10 weight
61.6%
Voting Authority Distribution
Total shares with voting rights: 37.98M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
37.98M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings26
Rows:
IONIS PHARMACEUTICALS INC
SOLEShares505.01K
TypeSH
Market value$17.66M
8.32%
Sole
0.00
Shared
505.01K
None
0.00
CYTOKINETICS INC
SOLEShares360K
TypeSH
Market value$16.93M
7.98%
Sole
0.00
Shared
360K
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.79M
TypeSH
Market value$15.14M
7.13%
Sole
0.00
Shared
1.79M
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares750K
TypeSH
Market value$14.38M
6.78%
Sole
0.00
Shared
750K
None
0.00
PLIANT THERAPEUTICS INC
SOLEShares1.05M
TypeSH
Market value$13.89M
6.55%
Sole
0.00
Shared
1.05M
None
0.00
ABIVAX SA
SOLEShares1.65M
TypeSH
Market value$12.07M
5.69%
Sole
0.00
Shared
1.65M
None
0.00
DYNAVAX TECHNOLOGIES CORP
SOLEShares860K
TypeSH
Market value$10.98M
5.18%
Sole
0.00
Shared
860K
None
0.00
NEUROGENE INC
SOLEShares442.76K
TypeSH
Market value$10.12M
4.77%
Sole
0.00
Shared
442.76K
None
0.00
EVOLUS INC
SOLEShares895.52K
TypeSH
Market value$9.89M
4.66%
Sole
0.00
Shared
895.52K
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares245.27K
TypeSH
Market value$9.61M
4.53%
Sole
0.00
Shared
245.27K
None
0.00
UNICYCIVE THERAPEUTICS INC
SOLEShares10.98M
TypeSH
Market value$8.72M
4.11%
Sole
0.00
Shared
10.98M
None
0.00
ZURA BIO LTD
SOLEShares3.17M
TypeSH
Market value$7.93M
3.73%
Sole
0.00
Shared
3.17M
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares3.01M
TypeSH
Market value$7.07M
3.33%
Sole
0.00
Shared
3.01M
None
0.00
JASPER THERAPEUTICS INC
SOLEShares322.38K
TypeSH
Market value$6.89M
3.25%
Sole
0.00
Shared
322.38K
None
0.00
MERUS N V
SOLEShares158.09K
TypeSH
Market value$6.65M
3.13%
Sole
0.00
Shared
158.09K
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares275K
TypeSH
Market value$6.00M
2.83%
Sole
0.00
Shared
275K
None
0.00
HELIX ACQUISITION CORP II
SOLEShares500K
TypeSH
Market value$5.25M
2.47%
Sole
0.00
Shared
500K
None
0.00
UPSTREAM BIO INC
SOLEShares300K
TypeSH
Market value$4.93M
2.32%
Sole
0.00
Shared
300K
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares4.68M
TypeSH
Market value$4.92M
2.32%
Sole
0.00
Shared
4.68M
None
0.00
VOYAGER THERAPEUTICS INC
SOLEShares826.75K
TypeSH
Market value$4.69M
2.21%
Sole
0.00
Shared
826.75K
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares228.80K
TypeSH
Market value$4.44M
2.09%
Sole
0.00
Shared
228.80K
None
0.00
MEREO BIOPHARMA GROUP PLC
SOLEShares1.15M
TypeSH
Market value$4.03M
1.90%
Sole
0.00
Shared
1.15M
None
0.00
REZOLUTE INC
SOLEShares621.89K
TypeSH
Market value$3.05M
1.44%
Sole
0.00
Shared
621.89K
None
0.00
PROMIS NEUROSCIENCES INC
SOLEShares2.65M
TypeSH
Market value$2.51M
1.18%
Sole
0.00
Shared
2.65M
None
0.00
OPTINOSE INC
SOLEShares370.27K
TypeSH
Market value$2.47M
1.17%
Sole
0.00
Shared
370.27K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IONIS PHARMACEUTICALS INCSOLE | COM | 505.01K | SH | $17.66M 8.32% | 0.00 | 505.01K | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 360K | SH | $16.93M 7.98% | 0.00 | 360K | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.79M | SH | $15.14M 7.13% | 0.00 | 1.79M | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 750K | SH | $14.38M 6.78% | 0.00 | 750K | 0.00 |
PLIANT THERAPEUTICS INCSOLE | COM | 1.05M | SH | $13.89M 6.55% | 0.00 | 1.05M | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.65M | SH | $12.07M 5.69% | 0.00 | 1.65M | 0.00 |
DYNAVAX TECHNOLOGIES CORPSOLE | COM NEW | 860K | SH | $10.98M 5.18% | 0.00 | 860K | 0.00 |
NEUROGENE INCSOLE | COM | 442.76K | SH | $10.12M 4.77% | 0.00 | 442.76K | 0.00 |
EVOLUS INCSOLE | COM | 895.52K | SH | $9.89M 4.66% | 0.00 | 895.52K | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 245.27K | SH | $9.61M 4.53% | 0.00 | 245.27K | 0.00 |
UNICYCIVE THERAPEUTICS INCSOLE | COM | 10.98M | SH | $8.72M 4.11% | 0.00 | 10.98M | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 3.17M | SH | $7.93M 3.73% | 0.00 | 3.17M | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 3.01M | SH | $7.07M 3.33% | 0.00 | 3.01M | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 322.38K | SH | $6.89M 3.25% | 0.00 | 322.38K | 0.00 |
MERUS N VSOLE | COM | 158.09K | SH | $6.65M 3.13% | 0.00 | 158.09K | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 275K | SH | $6.00M 2.83% | 0.00 | 275K | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 500K | SH | $5.25M 2.47% | 0.00 | 500K | 0.00 |
UPSTREAM BIO INCSOLE | COM | 300K | SH | $4.93M 2.32% | 0.00 | 300K | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 4.68M | SH | $4.92M 2.32% | 0.00 | 4.68M | 0.00 |
VOYAGER THERAPEUTICS INCSOLE | COM | 826.75K | SH | $4.69M 2.21% | 0.00 | 826.75K | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 228.80K | SH | $4.44M 2.09% | 0.00 | 228.80K | 0.00 |
MEREO BIOPHARMA GROUP PLCSOLE | SPON ADS | 1.15M | SH | $4.03M 1.90% | 0.00 | 1.15M | 0.00 |
REZOLUTE INCSOLE | COM NEW | 621.89K | SH | $3.05M 1.44% | 0.00 | 621.89K | 0.00 |
PROMIS NEUROSCIENCES INCSOLE | COM NEW | 2.65M | SH | $2.51M 1.18% | 0.00 | 2.65M | 0.00 |
OPTINOSE INCSOLE | COM NEW | 370.27K | SH | $2.47M 1.17% | 0.00 | 370.27K | 0.00 |
Page 1 of 2